Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 Mar;22(3):303-7.
doi: 10.1007/s11606-006-0021-3.

Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study

Joan M Cook  1 , Randall Marshall, Christina Masci, James C Coyne
Affiliations
Comparative Study

Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study

Joan M Cook et al. J Gen Intern Med. 2007 Mar.

Abstract

Background: There is a continued high prevalence of benzodiazepine use by older community-residing adults and of their continued prescription by practitioners, despite well known adverse effects and the availability of safer, effective alternatives.

Objectives: To understand factors influencing chronic use of benzodiazepines in older adults.

Design: Qualitative study, semistructured interviews with physicians.

Participants: Thirty-three practicing primary care physicians around Philadelphia.

Approach: Qualitative interviews were audiotaped, transcribed, and entered into a qualitative software program. A multidisciplinary team coded transcripts and developed themes.

Results: Physicians generally endorsed benzodiazepines as effective treatment for anxiety, citing quick action and strong patient satisfaction. The use of benzodiazepines in older adults was not seen to be problematic because they did not show drug-seeking or escalating dose behavior suggesting addiction. Physicians minimized other risks of benzodiazepines and did not view monitoring or restricting renewal of prescriptions as an important clinical focus relative to higher-priority medical issues. Many physicians expressed skepticism about risks of continued use and considerable pessimism in the successful taper/discontinuation in older patients with long-term use and prior failed attempts. Physicians also anticipated patient resistance to any such efforts, including switching physicians.

Conclusions: Primary care physicians are averse to addressing the public health problem of benzodiazepine overuse in the elderly. Their attitudes generally conflict with practice guidelines and they complain of a lack of training in constructive strategies to address this problem. A 2-pronged effort should focus on increasing skill level and preventing new cases of benzodiazepine dependency through improved patient education and vigilant monitoring of prescription renewal.

PubMed Disclaimer

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.278.1.27', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.278.1.27'}, {'type': 'PubMed', 'value': '9207334', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9207334/'}]}
    2. Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA. 1997;278:27–31. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9640992', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9640992/'}]}
    2. Pomara N, Tun H, DaSilva D, Hernando R, Deptula D, Greenblatt DJ. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation. Psychopharmacol Bull. 1998;34:139–53. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9434668', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9434668/'}]}
    2. Ried LD, Johnson RE, Gettman DA. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc. 1998;46:71–6. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11384896', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11384896/'}]}
    2. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001;158:892–8. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1136/bmj.38623.768588.47', 'is_inner': False, 'url': 'https://doi.org/10.1136/bmj.38623.768588.47'}, {'type': 'PMC', 'value': 'PMC1285093', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1285093/'}, {'type': 'PubMed', 'value': '16284208', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16284208/'}]}
    2. Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169–73. - PMC - PubMed

Publication types

Substances